A pilot lung cancer screening programme, which the NHS said had helped save lives, was being rolled out to more areas. The ...

The A5 nanobody is around 10 times smaller than conventional antibodies, helping it to penetrate deep into tissues. Crucially, it can bind selectively to cancer cells, leading to a reduction of more ...

Rates of the world's deadliest cancer appear to be low in sub-Saharan Africa. But that statistic is masking the scope of the ...

Never-smokers exposed to high levels of fine particulate air pollution have a significantly greater risk of developing lung ...

Jonathan Thompson, MD, MS, emphasized that comprehensive biomarker testing with next-generation sequencing and PD-L1 analysis—implemented as reflex testing at biopsy—is essential to guide precision ...

Lung cancer, the second-most common cancer in the U.S., is often associated with smoking — but even those who have never had a cigarette could be at risk of the deadly disease.

In the national examination, the elderly are sometimes excluded from the subject due to efficiency issues.However, a domestic ...

The FDA approved Hernexeos for adults with unresectable or metastatic non-squamous non-small cell lung cancer.

The treatment is one for those suffering with lung cancer who never smoked, a group of patients who account for up to 25% of ...

Allergic rhinitis is negatively associated with lung cancer risk, and that protective effect is particularly significant among men. Individuals with allergies have a 0.25-fold reduced risk for ...

A research team has developed a nanobody-based technology that can precisely identify and attack only lung cancer cells, ...

Many different coughs are symptoms of lung cancer. The type of cough depends on where the tumor is located and how it affects the lungs, but there isn’t one specific type of cough that would ...